Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

BACKGROUND: Lung immune prognostic index (LIPI) is a prognostic marker of extensive-stage small cell lung cancer (ES-SCLC) patients received immunotherapy or chemotherapy. However, its ability in limited-stage SCLC (LS-SCLC) should be evaluated extensively. METHODS: We retrospectively enrolled 497 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bochen, Hou, Qing, Liang, Yu, Xue, Shuqin, Yao, Ningning, Wei, Lijuan, Cao, Xin, Li, Hongwei, Si, Hongwei, Cao, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706962/
https://www.ncbi.nlm.nih.gov/pubmed/36447193
http://dx.doi.org/10.1186/s12885-022-10351-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706962/
https://www.ncbi.nlm.nih.gov/pubmed/36447193
http://dx.doi.org/10.1186/s12885-022-10351-7

Ejemplares similares